Enlivex Ltd.
Enlivex Ltd. (ENLV): 2 pipeline candidates · 5 clinical trials. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
N/A
D/E 0.20 · 0% dilution
Lead: Phase 2
2 candidates
N/A
N/A
A transparent, data-derived signal for Enlivex Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$154.0M
Cash
$2.4M
Quarterly Burn
—
Runway
—
Revenue
—
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| allocetra | Phase 2 |
| allocetra-ots | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
33
Total value held
$3.1M
| Holder | Shares | Value |
|---|---|---|
| diametric capital, lp | 1,483,178 | $1.4M |
| ark investment management llc | 628,310 | $584K |
| prelude capital management, llc | 225,738 | $210K |
| two sigma investments, lp | 146,412 | $136K |
| bank of america corp /de/ | 130,401 | $121K |
| renaissance technologies llc | 128,192 | $119K |
| goldman sachs group inc | 102,093 | $95K |
| xtx topco ltd | 100,362 | $93K |
| morgan stanley | 98,333 | $91K |
| geode capital management, llc | 80,560 | $75K |
Showing top 10 of 33 institutional holders of Enlivex Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Enlivex Ltd.'s pipeline?
Enlivex Ltd. (ENLV) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Enlivex Ltd.'s lead drug candidate?
Enlivex Ltd.'s most advanced tracked candidate is allocetra (Phase 2) for Osteoarthritis, Knee; Primary Knee Osteoarthritis; Arthritis, Psoriatic.
What is Enlivex Ltd.'s market capitalization?
Enlivex Ltd.'s market capitalization is approximately $154.0M.
Who is the CEO of Enlivex Ltd.?
Dr. Oren Hershkovitz Ph.D. is the chief executive officer of Enlivex Ltd. (ENLV).
Get the full picture on Enlivex Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.